This article is more than 5 years old. Information may no longer be current.
AACI appoints new board members
Click Here to Manage Email Alerts
Stanton L. Gerson, MD, Patrick J. Loehrer, Sr., MD, and Thomas A. Sellers, PhD, MPH, have been elected to the Association of American Cancer Institutes’ board of directors.
Elected as vice-president/president-elect, Gerson is the current director of the NCI-designated Case Comprehensive Cancer Center and founding director of the National Center for Regenerative Medicine. He also serves as director of University Hospitals Seidman Cancer Center as well as a member of the NCI Board of Scientific Advisors.
Loehrer is director of the Indiana University Melvin and Bren Simon Cancer Center. Sellers serves as director and executive vice president of the Moffitt Cancer Center and Research Institute.
In a statement to AACI membership, Gerson noted that in his leadership role, he intends to prioritize three critical aspects of the nation’s cancer centers program by:
- Encouraging the centers to work more closely together to lower health care costs and improve outcomes through nationally coordinated research and translation;
- Expanding the use of cancer patient data to further health improvements and research discoveries; and
- Making optimal use of the cancer center director and administrative leader network, including partnering with funding agencies, to set the policy agenda for cancer research, dissemination of discoveries, and cancer health care.
“I look forward to Stan’s expanded leadership position with AACI,” AACI executive director Barbara Duffy Stewart, said in a press release. “As both a researcher and administrator, Stan possesses the expertise and range of skills that will propel AACI’s continued support of its members’ collaborative efforts toward a cancer-free world.”
Gerson, Loehrer and Sellers’ terms will begin on October 27 during the AACI and Cancer Center Administrators Forum annual meeting, in Chicago, October 26-28.